{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:34:03Z","timestamp":1771295643251,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1038\/eye.2000.16","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T12:41:35Z","timestamp":1309956095000},"page":"73-77","source":"Crossref","is-referenced-by-count":27,"title":["Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Anastasios G P","family":"Konstas,","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Maltezos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Bufidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison C","family":"Hudgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFeye200016_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3928\/1542-8877-19970201-05","volume":"28","author":"AGP Konstas","year":"1997","unstructured":"Konstas AGP, Stewart WC, Stroman GA, et al. Clinical presentation and initial treatment patterns in patients with exfoliation versus primary open-angle glaucoma. Ophthalmic Surg Lasers 1997;28:111\u20137.","journal-title":"Ophthalmic Surg Lasers"},{"key":"BFeye200016_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/archopht.1997.01100150184006","volume":"115","author":"AGP Konstas","year":"1997","unstructured":"Konstas AGP, Mantziris DA, Stewart WC Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997;115:182\u20135.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/archopht.1997.01100160145002","volume":"115","author":"AGP Konstas","year":"1997","unstructured":"Konstas AGP, Mantziris DA, Cate EA, et al. Effect of timolol on the diurnal lOP in exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997;115:975\u20139.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR4","unstructured":"Book SA . Essentials of statistics. New York: McGraw Hill, 1978:117-22, 205-15."},{"key":"BFeye200016_CR5","unstructured":"Stewart We, Cate EA, Pruitt CA . Additivity of latanoprost 0.0005% to timolol hemihydrate 0.5% in ocular hypertensive or chronic open-angle glaucoma patients. Ciba Vision Ophthalmics internal report, 1997."},{"key":"BFeye200016_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0002-9394(14)73366-5","volume":"100","author":"J Feghali","year":"1985","unstructured":"Feghali J, Kaufman P . Decreased intraocular pressure in the hypertensive human eye with betaxolol, a pj-adrenergic antagonist. Am J Ophthalmol 1985;100:777\u201382.","journal-title":"Am J Ophthalmol"},{"key":"BFeye200016_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJM198408163110705","volume":"311","author":"L Moses","year":"1984","unstructured":"Moses L, Emerson J, Hosseini H . Statistics in practice: analysing data from ordered categories. N Engl J Med 1984;311:442\u20138.","journal-title":"N Engl J Med"},{"key":"BFeye200016_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archopht.1991.01080090123036","volume":"109","author":"RF Wang","year":"1991","unstructured":"Wang RF, Serle JB, Podos SM, Sugrue MF . MK-507 (L-671, 152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297\u20139.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1001\/archopht.116.11.1438","volume":"116","author":"LL Wayman","year":"1998","unstructured":"Wayman LL, Larsson L-I, Maus TL, Brubaker RF . Additive effect of dorzolamide on aqueous humor flow in patients receiving long-term treatment with timolol. Arch Ophthalmol 1998;116:1438\u201340.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/archopht.116.1.19","volume":"116","author":"A Larrson L-I, Aim","year":"1998","unstructured":"Larrson L-I, Aim A . Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide. Arch Ophthalmol 1998;116:19\u201324.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR11","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/archopht.1997.01100160538002","volume":"115","author":"L Wayman","year":"1997","unstructured":"Wayman L, Larsson L-I, Maus T, Aim A, Brubaker R . Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:1368\u201371.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archopht.1997.01100150047008","volume":"115","author":"TL Maus","year":"1997","unstructured":"Maus TL, Larsson L-I, McLaren JW, Brubaker RF . Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:45\u20139.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR13","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0161-6420(98)98043-5","volume":"105","author":"BD Vanlandingham","year":"1998","unstructured":"Vanlandingham BD, Maus TL, Brubaker RF . The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep. Ophthalmology 1998;105:1537\u201340.","journal-title":"Ophthalmology"},{"key":"BFeye200016_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archopht.1992.01080160073033","volume":"110","author":"EA Lippa","year":"1992","unstructured":"Lippa EA, Carlson LE, Ehinger B, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;110:495\u20139.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0161-6420(91)32295-4","volume":"98","author":"EA Lippa","year":"1991","unstructured":"Lippa EA, Schuman JS, Higginbotham EJ, et al. MK-507 versus sezolamide: comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology 1991;98:308\u201313.","journal-title":"Ophthalmology"},{"key":"BFeye200016_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archopht.1993.01090100051026","volume":"111","author":"M Wilkerson","year":"1993","unstructured":"Wilkerson M, Cyrlin M, Lippa EA, et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343\u201350.","journal-title":"Arch Ophthalmol"},{"key":"BFeye200016_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00061198-199400340-00002","volume":"3","author":"Y Kitazawa","year":"1994","unstructured":"Kitazawa Y, Azuma I, Iwata K, et al. Dorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose response study in patients with glaucoma or ocular hypertension. J Glaucoma 1994;3:275\u20139.","journal-title":"J Glaucoma"},{"key":"BFeye200016_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archopht.1995.01100080061030","volume":"113","author":"E Strahlman","year":"1995","unstructured":"Strahlman E, Tipping R, Vogel R, et al. A double masked, randomized one-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 1995;113:1009\u201316.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"BFeye200016_CR19","first-page":"989","volume":"32","author":"G Nardin","year":"1991","unstructured":"Nardin G, Lewis R, Lippa EA, Keates E, Coleman A, Clineschmidt Panebianco D, et al. Activity of the topical CAI MK-507 bid when added to timolol bid. Invest Ophthalmol Vis Sci 1991;32 (Suppl):989.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye200016_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0161-6420(96)30509-5","volume":"103","author":"ER Strahlman","year":"1996","unstructured":"Strahlman ER, Vogel R, Tipping R, et al. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 1996;103:1283\u201393.","journal-title":"Ophthalmology"},{"key":"BFeye200016_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0161-6420(97)30348-0","volume":"104","author":"A Heijl","year":"1997","unstructured":"Heijl A, Strahlman E, Sverrisson T, et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation glaucoma or ocular hypertension. Ophthalmology 1997;104:137\u201342.","journal-title":"Ophthalmology"},{"issue":"Suppl","key":"BFeye200016_CR22","first-page":"1315","volume":"26","author":"JE Topper","year":"1985","unstructured":"Topper JE, Brubaker RF . Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 1985;26 (Suppl):1315\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye200016_CR23","unstructured":"Stewart WC . Current and future glaucoma therapy. Ciba Vision Ophthalmics Clinical Symposium, 1997:1\u201343."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye200016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye200016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye200016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:58:17Z","timestamp":1684429097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye200016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["BFeye200016"],"URL":"https:\/\/doi.org\/10.1038\/eye.2000.16","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}